Search research articles
Contact Us
Filters
Showing results (71-80 of 332) with videos related to
Page
of 34
Sort By:
Plos One
|
July 30, 2011
Rivastigmine lowers Aβ and increases sAPPα levels, which parallel elevated synaptic markers and metabolic activity in degenerating primary rat neurons
Jason A Bailey, Balmiki Ray, Nigel H Greig, et al.
Journal of Neuroscience Research
|
February 3, 2015
Tumor necrosis factor-α potentiates long-term potentiation in the rat dentate gyrus after acute hypoxia
Audrey M Wall, Gatambwa Mukandala, Nigel H Greig, et al.
The Biochemical Journal
|
March 7, 2012
Kinetics of Torpedo californica acetylcholinesterase inhibition by bisnorcymserine and crystal structure of the complex with its leaving group
Cecilia Bartolucci, Jure Stojan, Qian-sheng Yu, et al.
The Lancet. Psychiatry
|
August 8, 2015
What can triumphs and tribulations from drug research in Alzheimer's disease tell us about the development of psychotropic drugs in general?
Robert E Becker, Mary V Seeman, Nigel H Greig, et al.
Current Neuropharmacology
|
August 4, 2025
Advancing Alzheimer's Diagnosis with AI-Enhanced MRI: A Review of Challenges and Implications
Zahra Batool, ShanShan Hu, Mohammad Amjad Kamal, et al.
International Journal of Molecular Sciences
|
April 29, 2009
Physiological and pathological role of alpha-synuclein in Parkinson's disease through iron mediated oxidative stress; the role of a putative iron-responsive element
David Olivares, Xudong Huang, Lars Branden, et al.
The Journal of Clinical Investigation
|
February 16, 2026
The promise of GLP-1 receptor agonists for neurodegenerative diseases
Dilan Athauda, Nigel H Greig, Wassilios G Meissner, et al.
The Open Biochemistry Journal
|
July 28, 2011
Thalidomide Analogues Suppress Lipopolysaccharide-Induced Synthesis of TNF-α and Nitrite, an Intermediate of Nitric Oxide, in a Cellular Model of Inflammation
David Tweedie, Kathryn A Frankola, Weiming Luo, et al.
CNS & Neurological Disorders Drug Targets
|
June 13, 2025
Zebrafish-Based Parkinson's Disease Models: Unveiling Genetic Mechanisms and Therapeutic Pathways
Rohinee Dodiya, Pratishtha Sharma, Dipa Israni, et al.
Neuropharmacology
|
May 22, 2018
Are Alzheimer's disease and other neurodegenerative disorders caused by impaired signalling of insulin and other hormones?
Christian Hölscher, Fernanda G De Felice, Nigel H Greig, et al.
Page
of 34
Search research articles
Search
Showing results (71-80 of 332) with videos related to
Sort By:
Page
of 34
Plos One
|
July 30, 2011
Rivastigmine lowers Aβ and increases sAPPα levels, which parallel elevated synaptic markers and metabolic activity in degenerating primary rat neurons
Jason A Bailey, Balmiki Ray, Nigel H Greig, et al.
Journal of Neuroscience Research
|
February 3, 2015
Tumor necrosis factor-α potentiates long-term potentiation in the rat dentate gyrus after acute hypoxia
Audrey M Wall, Gatambwa Mukandala, Nigel H Greig, et al.
The Biochemical Journal
|
March 7, 2012
Kinetics of Torpedo californica acetylcholinesterase inhibition by bisnorcymserine and crystal structure of the complex with its leaving group
Cecilia Bartolucci, Jure Stojan, Qian-sheng Yu, et al.
The Lancet. Psychiatry
|
August 8, 2015
What can triumphs and tribulations from drug research in Alzheimer's disease tell us about the development of psychotropic drugs in general?
Robert E Becker, Mary V Seeman, Nigel H Greig, et al.
Current Neuropharmacology
|
August 4, 2025
Advancing Alzheimer's Diagnosis with AI-Enhanced MRI: A Review of Challenges and Implications
Zahra Batool, ShanShan Hu, Mohammad Amjad Kamal, et al.
International Journal of Molecular Sciences
|
April 29, 2009
Physiological and pathological role of alpha-synuclein in Parkinson's disease through iron mediated oxidative stress; the role of a putative iron-responsive element
David Olivares, Xudong Huang, Lars Branden, et al.
The Journal of Clinical Investigation
|
February 16, 2026
The promise of GLP-1 receptor agonists for neurodegenerative diseases
Dilan Athauda, Nigel H Greig, Wassilios G Meissner, et al.
The Open Biochemistry Journal
|
July 28, 2011
Thalidomide Analogues Suppress Lipopolysaccharide-Induced Synthesis of TNF-α and Nitrite, an Intermediate of Nitric Oxide, in a Cellular Model of Inflammation
David Tweedie, Kathryn A Frankola, Weiming Luo, et al.
CNS & Neurological Disorders Drug Targets
|
June 13, 2025
Zebrafish-Based Parkinson's Disease Models: Unveiling Genetic Mechanisms and Therapeutic Pathways
Rohinee Dodiya, Pratishtha Sharma, Dipa Israni, et al.
Neuropharmacology
|
May 22, 2018
Are Alzheimer's disease and other neurodegenerative disorders caused by impaired signalling of insulin and other hormones?
Christian Hölscher, Fernanda G De Felice, Nigel H Greig, et al.
Page
of 34